Literature DB >> 23299478

Intraocular hemorrhage causes retinal vascular dysfunction via plasma kallikrein.

Jia Liu1, Allen C Clermont, Ben-Bo Gao, Edward P Feener.   

Abstract

PURPOSE: Retinal hemorrhages occur in a variety of sight-threatening conditions including ocular trauma, high altitude retinopathy, and chronic diseases such as diabetic and hypertensive retinopathies. The goal of this study is to investigate the effects of blood in the vitreous on retinal vascular function in rats.
METHODS: Intravitreal injections of autologous blood, plasma kallikrein (PK), bradykinin, and collagenase were performed in Sprague-Dawley and Long-Evans rats. Retinal vascular permeability was measured using vitreous fluorophotometry and Evans blue dye permeation. Leukostasis was measured by fluorescein isothiocyanate-coupled concanavalin A lectin and acridine orange labeling. Retinal hemorrhage was examined on retinal flatmounts. Primary cultures of bovine retinal pericytes were cultured in the presence of 25 nM PK for 24 hours. The pericyte-conditioned medium was collected and the collagen proteome was analyzed by tandem mass spectrometry.
RESULTS: Intravitreal injection of autologous blood induced retinal vascular permeability and retinal leukostasis, and these responses were ameliorated by PK inhibition. Intravitreal injections of exogenous PK induced retinal vascular permeability, leukostasis, and retinal hemorrhage. Proteomic analyses showed that PK increased collagen degradation in pericyte-conditioned medium and purified type IV collagen. Intravitreal injection of collagenase mimicked PK's effect on retinal hemorrhage.
CONCLUSIONS: Intraocular hemorrhage increases retinal vascular permeability and leukostasis, and these responses are mediated, in part, via PK. Intravitreal injections of either PK or collagenase, but not bradykinin, induce retinal hemorrhage in rats. PK exerts collagenase-like activity that may contribute to blood-retinal barrier dysfunction.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23299478      PMCID: PMC3567752          DOI: 10.1167/iovs.12-10537

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  47 in total

1.  Pericytes regulate the blood-brain barrier.

Authors:  Annika Armulik; Guillem Genové; Maarja Mäe; Maya H Nisancioglu; Elisabet Wallgard; Colin Niaudet; Liqun He; Jenny Norlin; Per Lindblom; Karin Strittmatter; Bengt R Johansson; Christer Betsholtz
Journal:  Nature       Date:  2010-10-13       Impact factor: 49.962

Review 2.  Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures.

Authors:  Niall Patton; Tariq Aslam; Thomas Macgillivray; Alison Pattie; Ian J Deary; Baljean Dhillon
Journal:  J Anat       Date:  2005-04       Impact factor: 2.610

3.  Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation.

Authors:  Ben-Bo Gao; Allen Clermont; Susan Rook; Stephanie J Fonda; Vivek J Srinivasan; Maciej Wojtkowski; James G Fujimoto; Robert L Avery; Paul G Arrigg; Sven-Erik Bursell; Lloyd Paul Aiello; Edward P Feener
Journal:  Nat Med       Date:  2007-01-28       Impact factor: 53.440

4.  Mast cells increase vascular permeability by heparin-initiated bradykinin formation in vivo.

Authors:  Chris Oschatz; Coen Maas; Bernd Lecher; Thomas Jansen; Jenny Björkqvist; Thomas Tradler; Reinhard Sedlmeier; Peter Burfeind; Sven Cichon; Sven Hammerschmidt; Werner Müller-Esterl; Walter A Wuillemin; Gunnar Nilsson; Thomas Renné
Journal:  Immunity       Date:  2011-02-25       Impact factor: 31.745

5.  Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding.

Authors:  Alexey S Revenko; Dacao Gao; Jeff R Crosby; Gourab Bhattacharjee; Chenguang Zhao; Chris May; David Gailani; Brett P Monia; A Robert MacLeod
Journal:  Blood       Date:  2011-08-05       Impact factor: 22.113

Review 6.  Inflammation after intracerebral hemorrhage.

Authors:  Jian Wang; Sylvain Doré
Journal:  J Cereb Blood Flow Metab       Date:  2006-10-11       Impact factor: 6.200

7.  Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice.

Authors:  Leif R Lund; Kirsty A Green; Allart A Stoop; Michael Ploug; Kasper Almholt; Jennifer Lilla; Boye S Nielsen; Ib J Christensen; Charles S Craik; Zena Werb; Keld Danø; John Rømer
Journal:  EMBO J       Date:  2006-06-08       Impact factor: 11.598

8.  Angiostatic effect of penetrating ocular injury: role of pigment epithelium-derived factor.

Authors:  John S Penn; Gary W McCollum; Joshua M Barnett; Xiang Q Werdich; Katherine A Koepke; Veera S Rajaratnam
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-01       Impact factor: 4.799

9.  Delayed appearance of high altitude retinal hemorrhages.

Authors:  Daniel Barthelmes; Martina M Bosch; Tobias M Merz; Benno L Petrig; Frederic Truffer; Konrad E Bloch; Timothy A Holmes; Philippe Cattin; Urs Hefti; Miriam Sellner; Florian K P Sutter; Marco Maggiorini; Klara Landau
Journal:  PLoS One       Date:  2011-02-17       Impact factor: 3.240

10.  Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein.

Authors:  Jia Liu; Ben-Bo Gao; Allen C Clermont; Price Blair; Tamie J Chilcote; Sukanto Sinha; Robert Flaumenhaft; Edward P Feener
Journal:  Nat Med       Date:  2011-01-23       Impact factor: 53.440

View more
  13 in total

1.  Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema.

Authors:  Takeshi Kita; Allen C Clermont; Nivetha Murugesan; Qunfang Zhou; Kimihiko Fujisawa; Tatsuro Ishibashi; Lloyd Paul Aiello; Edward P Feener
Journal:  Diabetes       Date:  2015-05-15       Impact factor: 9.461

2.  Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke.

Authors:  Fabrício Simão; Tuna Ustunkaya; Allen C Clermont; Edward P Feener
Journal:  Blood       Date:  2017-01-27       Impact factor: 22.113

3.  Angiogenic Factors and Cytokines in Diabetic Retinopathy.

Authors:  Steven F Abcouwer
Journal:  J Clin Cell Immunol       Date:  2013

Review 4.  Role of plasma kallikrein in diabetes and metabolism.

Authors:  E P Feener; Q Zhou; W Fickweiler
Journal:  Thromb Haemost       Date:  2013-05-16       Impact factor: 5.249

Review 5.  Thrombosis and Hemorrhage in Diabetic Retinopathy: A Perspective from an Inflammatory Standpoint.

Authors:  Nivetha Murugesan; Tuna Üstunkaya; Edward P Feener
Journal:  Semin Thromb Hemost       Date:  2015-08-25       Impact factor: 4.180

Review 6.  The Effects of the Contact Activation System on Hemorrhage.

Authors:  Fabrício Simão; Edward P Feener
Journal:  Front Med (Lausanne)       Date:  2017-07-31

7.  A pharmacological approach in newly established retinal vein occlusion model.

Authors:  Shinichiro Fuma; Anri Nishinaka; Yuki Inoue; Kazuhiro Tsuruma; Masamitsu Shimazawa; Mineo Kondo; Hideaki Hara
Journal:  Sci Rep       Date:  2017-03-02       Impact factor: 4.379

8.  Frosted branch angiitis with penetrating ocular trauma and retained intraocular foreign body.

Authors:  V G Madanagopalan; C K Nagesha; Girish Velis; Santosh Devulapally; S Balamurugan
Journal:  Indian J Ophthalmol       Date:  2018-07       Impact factor: 1.848

9.  Plasma Kallikrein Contributes to Intracerebral Hemorrhage and Hypertension in Stroke-Prone Spontaneously Hypertensive Rats.

Authors:  Jian Guan; Allen C Clermont; Loc-Duyen Pham; Tuna Ustunkaya; Alexey S Revenko; A Robert MacLeod; Edward P Feener; Fabrício Simão
Journal:  Transl Stroke Res       Date:  2021-07-09       Impact factor: 6.829

10.  Identification of Potential Biomarkers for Rhegmatogenous Retinal Detachment Associated with Choroidal Detachment by Vitreous iTRAQ-Based Proteomic Profiling.

Authors:  Zhifeng Wu; Nannan Ding; Mengxi Yu; Ke Wang; Shasha Luo; Wenjun Zou; Ying Zhou; Biao Yan; Qin Jiang
Journal:  Int J Mol Sci       Date:  2016-12-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.